Commissioner Califf: Cardiologist, Clinical Trials Expert Ascends At FDA
This article was originally published in The Gray Sheet
Executive Summary
The Senate confirmed Robert Califf as the new FDA commissioner after months of delay, giving the cardiologist, clinical trial expert and established agency official a better platform to push his priorities, which include combination product and clinical data-collection reforms, while implementing projects already under way.